Bioliberty raises $3.3M series a

◆ Amount

$3.3M

◆ Announced

2 Nov 2026

◆ Company

◆ Source

◆ The Round

Bioliberty raised $3.3M in series a funding, announced on 2 November 2026, led by Scottish National Investment Bank, TGH Ventures, Ballad Ventures, 25M Health, Whiterock, with participation from Archangels, Eos Advisory, Old College Capital, Hanna Capital SEZC, Conduit Connect. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Bioliberty

Edinburgh-based developer of robotic rehabilitation and physical therapy technology, specifically an AI-powered robotic glove platform for stroke survivors and neurological patients. Bioliberty is based in United Kingdom and currently at series a stage, operating in Medtech, Healthtech Infrastructure.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links Bioliberty's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market